Stepan Company (SCL) Fair Value 2026

SCL · Specialty Chemicals ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.4 /10

32 fundamental signals · 11 models active

Value Trap Risk

LOW (26/100)

Quick Summary — As of 2026-08-27, Stepan Company (SCL) trades at $62.81, versus a $51.28 median fair value across its 11 active models — 18.4% below the current price. QOC: 7.4/10. Value Trap Risk: 26/100 (LOW). 11/13 models active.

Key Facts

Ticker
SCL
Price
$62.81
Quality Score
7.4/10
Value Trap Risk
26/100
Models Active
11/13
Last Updated
Strength: First Chicago suggests +207.1% upside with 58% confidence
Risk: Majority of models suggest overvaluation

Is Stepan Company (SCL) Undervalued or Overvalued in 2026?

According to CirclFi’s 11-model valuation engine, Stepan Company (SCL) appears overvalued as of : the median of 11 independent fair value estimates is $51.28, 18.4% below the current price of $62.81. Estimates range from $8.82 to $192.92. SCL scores 7.4/10 on fundamental quality and 26/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. SCL’s -18.4% gap is narrower than that market norm, and the Specialty Chemicals sector median is -35.9%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Stepan Company Stock in 2026? →

What Fair Value Does Each Model Give SCL?

11 Intrinsic Value Models vs. Current Price ($62.81)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $26.49 -57.8%
Ensemble · Low Conviction
 $51.28 -18.4%
Scenario · High Conviction
 $192.92 +207.1%
Intrinsic · High Conviction
 $34.25 -45.5%
Unlock the Full Matrix

Access 7 additional models including Markov DDM, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 11 Models →

Cancel anytime · No contracts · Instant access

What Is SCL's Fair Value Range?

Spread across 11 independent models · $8.82 to $192.92

CirclFi's 11 active models place Stepan Company (SCL) between $8.82 and $192.92 per share, a spread of 359% of the median. The median of that range — $51.28 — is the fair value CirclFi publishes for SCL, against a current price of $62.81.

Low · ML-RIVHigh · First Chicago
$8.82median $51.28$192.92
Where the range comes from
Most bearish modelML Residual Income$8.82
Most bullish modelFirst Chicago$192.92
Model agreement4 bullish · 7 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for SCL. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on SCL, not a CirclFi price target. How each model works →

What Is Stepan Company (SCL) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Stepan Company's intrinsic value is estimated at a median fair value of $51.28. Trading at $62.81, the stock is approaching fair value or slight overvaluation (implied return of -18.4%), as 7 of 11 models suggest limited further upside. Notably, First Chicago sees the most upside at +207.1% (fair value: $192.92), while ML-RIV is the most conservative at -86.0% ($8.82). The spread between these extremes — +293.1% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About SCL?

11 of 13 models are currently active for SCL. Of these, 4 models suggest upside while 7 models suggest overvaluation. Taken together, their median fair value for SCL is $51.28 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does SCL Rank in Specialty Chemicals?

Among 69 Specialty Chemicals stocks, SCL ranks #24 by Quality of Company score. CirclFi's QOC score of 7.4/10 evaluates 32 fundamental signals. A score of 7.4 indicates above-average quality.

See all Most Undervalued Specialty Chemicals Stocks →

The Specialty Chemicals sector introduces analytical considerations specific to manufacturing company businesses. For Stepan Company, metrics like organic revenue growth provide important context that general-purpose valuation models may underweight.

Is SCL a Value Trap?

CirclFi's Value Trap algorithm assigns SCL a score of 26/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

11 of 13 models are active for Stepan Company. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Stepan Company earns a quality score of 7.4/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +293.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SCL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SCL's 11 active models, average confidence is 48%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Stepan Company Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Specialty Chemicals Stocks Should You Also Analyze?

11 related Specialty Chemicals stocks with 13-model coverage

HDSNHudson Technologies, Inc.QOC 7.6FULH.B. Fuller CompanyQOC 7.4SSLSasol LimitedQOC 7.7KOPKoppers Holdings Inc.QOC 7.4EMNEastman Chemical CompanyQOC 7.8KWRQuaker Chemical CorporationQOC 7.3APDAir Products and Chemicals, Inc.QOC 6.5AMTXAemetis, Inc.QOC 4.5NEUNewMarket CorporationQOC 8.8ODCOil-Dri Corporation of AmericaQOC 9.2RPMRPM International Inc.QOC 9.0

Read investment analysis: HDSN · FUL · SSL · KOP · EMN · KWR · APD · AMTX · NEU · ODC · RPM

Which Other Stocks Have a Similar Quality Score to SCL?

7 companies across all industries closest to SCL’s Quality of Company score of 7.4/10.

FNWDFinward BancorpQOC 7.4NSLRNeostellar Capital Corp.QOC 7.4SBRASabra Health Care REIT, Inc.QOC 7.4SPROSpero Therapeutics, Inc.QOC 7.4RSVRReservoir Media, Inc.QOC 7.4TDThe Toronto-Dominion BankQOC 7.4NVDANVIDIA CorporationQOC 10.0

Read investment analysis: FNWD · NSLR · SBRA · SPRO · RSVR · TD · NVDA

Where Does SCL Sit in CirclFi's Specialty Chemicals Rankings?

SCL is ranked against every other Specialty Chemicals stock CirclFi covers in each of these screens.

See all Specialty Chemicals stocks ranked →

What Else Do Investors Ask About Stepan Company’s Valuation?

What is Stepan Company's intrinsic value in 2026?

CirclFi puts Stepan Company (SCL)'s intrinsic value at $51.28 — the median of 11 independent model estimates as of 2026-08-27, ranging from $8.82 to $192.92. The Quality of Company score is 7.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SCL overvalued or undervalued right now?

At $62.81, 4 of 11 active models suggest SCL may be undervalued, while 7 indicate potential overvaluation. The median of all 11 fair value estimates is $51.28, 18.4% below the current price of $62.81 — a consensus view that SCL is overvalued. The assessment depends on which methodology best fits Stepan Company's business model in Specialty Chemicals.

What does a Quality of Company score of 7.4 mean for SCL?

Stepan Company's QOC of 7.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on SCL?

CirclFi analyzes SCL with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 11 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on SCL?

Of the 11 models currently active on SCL, First Chicago is the most bullish at $192.92 per share, and ML Residual Income is the most bearish at $8.82. CirclFi's published fair value for SCL is the median of that range, $51.28, not either extreme. The gap between the two ends equals 359% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is SCL a value trap in 2026?

Stepan Company's Value Trap score is 26/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 11-model valuation engine, Stepan Company (SCL) has a median fair value of $51.28 — 18.4% below the current price of $62.81 — as of 2026-08-27.” Source: circlfi.com/stock/SCL/ · Methodology
Primary sources for this SCL valuation
  • Financial statements: Stepan Company 10-K and 10-Q filings on SEC EDGAR (CIK 0000094049) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for SCL as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 11 mathematical frameworks give you clarity on SCL.

Unlock All 11 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

7 models hidden for SCL Unlock All 11 — $39/mo